Literature DB >> 3389080

"Chronic painter's syndrome". A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls.

A Gade1, E L Mortensen, P Bruhn.   

Abstract

Twenty solvent-exposed workers, most of them painters, had been diagnosed as cases of toxic encephalopathy in 1978/79. Two years later they were re-examined with an extensive battery of neuropsychological tests. Their performance was unchanged on retesting. We have now compared their test results with those of non-exposed control subjects. Previous impressions of significant intellectual impairment in the solvent-exposed patients could not be confirmed when the influence of age, education, and intelligence was taken into consideration. The present group with presumed toxic encephalopathy is assumed to be representative of other patients who were similarly diagnosed in our department. The presently reanalyzed cases had been diagnosed as brain damaged and reported as such in the literature. Thus, they may have contributed to the formation of the concept of the "chronic painters' syndrome" with dementia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389080     DOI: 10.1111/j.1600-0404.1988.tb05913.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

1.  The clinical significance of sleep apnoea in workers exposed to organic solvents: implications for the diagnosis of organic solvent encephalopathy.

Authors:  P Monstad; S I Mellgren; I A Sulg
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

2.  Nervous system effects of toluene and other organic solvents.

Authors:  N Rosenberg
Journal:  West J Med       Date:  1989-05

Review 3.  Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: an epidemiological review.

Authors:  J M Balbus-Kornfeld; W Stewart; K I Bolla; B S Schwartz
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

4.  Current approaches to neurobehavioural testing in occupational health.

Authors:  A Spurgeon
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

5.  Neuropsychological findings in a non-clinical sample of workers exposed to solvents.

Authors:  I Reinvang; H M Borchgrevink; O Aaserud; V Lie; U F Malt; P Nakstad; P G Larsson; L Gjerstad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

Review 6.  Behavioral methods and organic solvents: questions and consequences.

Authors:  A Iregren
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

7.  Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

Authors:  S G Hasselbalch; G Oberg; S A Sørensen; A R Andersen; G Waldemar; J F Schmidt; K Fenger; O B Paulson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

8.  A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression.

Authors:  Ulla Knorr; Maj Vinberg; Anders Gade; Per Winkel; Christian Gluud; Jørn Wetterslev; Ulrik Gether; Lars Kessing
Journal:  Ther Adv Psychopharmacol       Date:  2011-10

9.  Chronic Exposure to Solvents Among Construction Painters: Reductions in Exposure and Neurobehavioral Health Effects.

Authors:  Nancy Fiedler; Clifford Weisel; Chizoba Nwankwo; Howard Kipen; Gudrun Lange; Pamela Ohman-Strickland; Robert Laumbach
Journal:  J Occup Environ Med       Date:  2018-12       Impact factor: 2.162

10.  Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.

Authors:  Ulla Knorr; Maj Vinberg; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Anders Gade; Eva Haastrup; Olaf Paulson; Jørn Wetterslev; Christian Gluud; Ulrik Gether; Lars Kessing
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.